The management of older patients with hodgkin lymphoma

Boris Böll, Andrew M. Evens

Research output: Chapter in Book/Report/Conference proceedingChapter


Survival rates for Hodgkin lymphoma (HL) have substantially improved during the past several decades. Using stage-adapted polychemotherapy regimens and innovative radiation techniques, 5-year progression-free survival (PFS) has reached almost 90 % in young patients. Since the median age at diagnosis is approximately 32 years, these excellent results account for the majority of patients. Unfortunately, this progress has not translated into a similar benefit for older patients, especially for advanced-stage disease. Survival rates for HL patients aged 60 years are significantly and disproportionately inferior compared with younger patient populations.

Original languageEnglish (US)
Title of host publicationHodgkin Lymphoma
Subtitle of host publicationA Comprehensive Overview, Second Edition
PublisherSpringer International Publishing
Number of pages16
ISBN (Electronic)9783319125053
ISBN (Print)9783319125046
StatePublished - Jan 1 2015
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'The management of older patients with hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this